Quantification of Anti-GP50, Anti-rT24H, and Anti-sTs18var1 Antibodies to Identify Viable Infection in Patients with Neurocysticercosis
The American Journal of Tropical Medicine and Hygiene · 07.01.2026 · 114 (1) · 134-137
DOI: 10.4269/ajtmh.25-0325 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 07.01.2026. Verfasst von Andrea Rivera und 5 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Peru. Hauptthemen laut MEDLINE: Neurocysticercosis, Taenia solium, Antibodies, Helminth, Antigens, Helminth. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Identifying viable infections in neurocysticercosis (NCC) is crucial for treatment. Neuroimaging is the primary diagnostic tool, but it is not widely available. Moreover, in many cases, imaging diagnosis is not pathognomonic and requires serological confirmation. The serological assay of choice, enzyme-linked immunoelectrotransfer blot using lentil lectin-purified glycoprotein (LLGP-EITB) Taenia solium antigens to detect specific antibodies, exhibits high predictive values for the presence of viable NCC when the results are positive for multiple (>3) antibody bands; it also exhibits high predictive values for the absence of viable infection when the results are negative or the test reacts to a single antibody band. However, its interpretation in terms of viable infection is limited in cases with two or three positive bands (intermediate results), which occur in one-quarter of patients with NCC. The quantification of specific antibodies could allow for the identification of viable infections. Using a multi-antigen, quantitative multiplex bead assay, antibody levels were measured against Taenia solium proteins rGP50, rT24H, and sTs18var1 in 94 patients with intermediate LLGP-EITB results. The antibody-to-rT24H (25.96 versus 5.49; P = 0.0048) and antibody-to-sTs18var1 ratios (3.62 versus 1.37; P = 0.0083) were higher in subjects with viable cysticerci than in controls. Patients with high antibody levels against the proteins rT24H and sTs18var1 were 5.4 times more likely to have a viable infection than those with low antibody levels. The quantification of antibodies against rT24H and sTs18var1 can help define a viable NCC infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Peru.
- Center for Global Health, Universidad Peruana Cayetano Heredia, Lima, Peru.
- Institute for Infection and Immunity, City St George's, University of London, London, United Kingdom.
- Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Zitieren
APA
Rivera, A., Toribio, L. M., Bustos, J. A., Saavedra, H., Gonzales, I., & García, H. H. (2026). Quantification of Anti-GP50, Anti-rT24H, and Anti-sTs18var1 Antibodies to Identify Viable Infection in Patients with Neurocysticercosis. The American Journal of Tropical Medicine and Hygiene, 114(1), 134-137. https://doi.org/10.4269/ajtmh.25-0325
Vancouver
Rivera A, Toribio LM, Bustos JA, Saavedra H, Gonzales I, García HH. Quantification of Anti-GP50, Anti-rT24H, and Anti-sTs18var1 Antibodies to Identify Viable Infection in Patients with Neurocysticercosis. The American Journal of Tropical Medicine and Hygiene. 2026;114(1):134-137. doi:10.4269/ajtmh.25-0325
BibTeX
@article{Rivera2026,
author = {Rivera, Andrea and Toribio, Luz M and Bustos, Javier A and Saavedra, Herbert and Gonzales, Isidro and García, Hector H},
title = {Quantification of Anti-GP50, Anti-rT24H, and Anti-sTs18var1 Antibodies to Identify Viable Infection in Patients with Neurocysticercosis},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2026},
volume = {114},
number = {1},
pages = {134--137},
doi = {10.4269/ajtmh.25-0325}
}
EUVIMED